ArticleFrontiers in oncology2022

Clinical implication of minimal residual disease assessment by next-generation sequencing-based immunoglobulin clonality assay in pediatric B-acute lymphoblastic leukemia.

Jae Wook Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.